These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1248010)

  • 1. The conversion of an ovariectomy-nonresponsive to an ovariectomy-responsive mammary tumor strain.
    Diamond EJ; Koprak S; Shen SK; Hollander VP
    Cancer Res; 1976 Jan; 36(1):77-80. PubMed ID: 1248010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
    Powell BL; Diamond EJ; Koprak S; Hollander VP
    Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
    Diamond EJ; Giladi M; Khan S; Hollander VP
    Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological significance of estradiol receptor binding to DNA.
    Khan S; Feldman M; Hollander VP
    Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ovariectomy-induced rat mammary tumor regression by a mammosomatotropic tumor.
    Diamond EJ; Khan S; Koprak S; Hollander VP
    Cancer Res; 1978 Aug; 38(8):2239-45. PubMed ID: 208762
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
    Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
    Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone, serum, and methylxanthine interactions in the regulation of DNA synthesis in organ-cultured rat mammary tumors.
    Mayer RM; Diamond EJ; Hollander VP
    J Natl Cancer Inst; 1980 Nov; 65(5):1033-8. PubMed ID: 6159497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC; Parsons JA
    Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between estrogens, prolactin, and growth hormone on the growth of N-nitrosomethylurea-induced rat mammary tumors.
    Rose DP; Gottardis M
    Anticancer Res; 1985; 5(4):397-402. PubMed ID: 4037735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and morphometric responses of heterogeneous populations of experimental breast cancer cells in vivo.
    Lancaster S; English HF; Demers LM; Manni A
    Cancer Res; 1988 Jun; 48(11):3276-81. PubMed ID: 3365706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
    Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
    Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prolactin in growth of the rat mammary tumor MTW9.
    Platica M; Doody J; Mandeli JP; Hollander VP
    Int J Cancer; 1991 Apr; 48(1):109-12. PubMed ID: 2019452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.
    Moreno-Cuevas JE; Sirbasku DA
    In Vitro Cell Dev Biol Anim; 2000; 36(7):410-27. PubMed ID: 11039493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrest of synthesis of specific proteins at the onset of mammary tumor regression.
    Rouleau M; Losonczy I; Gullino PM
    Cancer Res; 1978 Apr; 38(4):926-31. PubMed ID: 639047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of chromatofocusing to distinguish estradiol receptor from ovarian-dependent and -independent rat mammary tumors.
    Coufalik AH; Feldman M; Platica M; Toth L; Dreiling D; Hollander VP
    Cancer Res; 1983 Nov; 43(11):5235-9. PubMed ID: 6616460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin and estrogen binding in transplantable hormone-dependent and autonomous rat mammary carcinoma.
    Costlow ME; Buschow RA; Richert NJ; McGuire WL
    Cancer Res; 1975 Apr; 35(4):970-4. PubMed ID: 163700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
    Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
    Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
    Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
    Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.